Concepedia

Andrew B. Patterson

AB

Statistics

Publications

3

Citations

195

H-Index

3

Active since

2005

Affiliations

Charles River Laboratories (United Kingdom)(Current)

AstraZeneca (United Kingdom)

Andrew B. Patterson is an author at Charles River Laboratories (United Kingdom) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

2005–2010

3

Publications

3

Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor

David McKillop, E. A. Partridge, John Kemp et al. · Molecular Cancer Therapeutics · 2005 · 125 citations

Age dependent incorporation of 14C-DHA into rat brain and body tissues after dosing various 14C-DHA-esters

Brigitte A. Graf, Guus Duchateau, Andrew B. Patterson et al. · Prostaglandins Leukotrienes and Essential Fatty Acids · 2010 · 59 citations

, , +9

Distribution of radioactivity and metabolite profiling in tumour and plasma following intravenous administration of a colchicine derivative (<sup>14</sup>C-ZD6126) to tumour-bearing mice

R. A. D'Souza, E. A. Partridge, David W. Roberts et al. · Xenobiotica · 2007 · 11 citations

, , +22

1–3 of 3